Skip to content

EPS (Diluted) at other companies

Procter & Gamble logo
Procter & GamblePG
$1.63+5.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Bausch + Lomb logo
Bausch + LombBLCO
-$0.20+66.7%
Cencora logo
CencoraCOR
$8.40+128%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$0.40-5.3%
Organon logo
OrganonOGN
$0.55+66.7%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's EPS (diluted)?
Prestige Consumer Healthcare (PBH) reported EPS (diluted) of $1.13 in Q1 2026.
How has Prestige Consumer Healthcare's EPS (diluted) changed year-over-year?
Prestige Consumer Healthcare's EPS (diluted) increased by 11.9% year-over-year, from $1.01 to $1.13.
What is the long-term trend for Prestige Consumer Healthcare's EPS (diluted)?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's EPS (diluted) has grown at a -0.8% compound annual growth rate (CAGR), from $4.04 to $3.91.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.